Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-25-083815
Filing Date
2025-06-09
Accepted
2025-06-09 16:51:25
Documents
7
Period of Report
2025-05-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A 2025_annual_meeting_def_.htm DEF 14A 1367693
2 GRAPHIC img100387488_0.jpg GRAPHIC 15547
3 GRAPHIC img100387488_1.jpg GRAPHIC 15547
4 GRAPHIC img100387488_2.jpg GRAPHIC 477898
5 GRAPHIC img100387488_3.jpg GRAPHIC 202650
6 GRAPHIC img100387488_4.jpg GRAPHIC 266485
7 GRAPHIC img100387488_5.jpg GRAPHIC 197370
  Complete submission text file 0000950170-25-083815.txt   2987538
Mailing Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122
Business Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122 650-800-3717
REVELATION BIOSCIENCES, INC. (Filer) CIK: 0001810560 (see all company filings)

EIN.: 843898466 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39603 | Film No.: 251034816
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)